Header cover image

Israeli (TA) Pharma Industry Analysis

UpdatedSep 20, 2023
DataAggregated Company Financials
  • 7D3.8%
  • 3M-8.5%
  • 1Y-51.9%
  • YTD-32.2%

Over the last 7 days, the Pharma industry has risen 2.4%, driven by gains in InterCure and Rekah Pharmaceutical Industry of 4.6% and 6.6%, respectively. In the past year, the industry is down 51%. Earnings are forecast to grow by 86% annually.

Industry Valuation and Performance

Has the Israeli Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 20 Sep 2023₪701.9m₪958.8m-₪209,843,054.0014.1x-3.3x0.7x
Fri, 18 Aug 2023₪646.1m₪918.8m-₪128,230,912.008.3x-5x0.7x
Sun, 16 Jul 2023₪672.6m₪918.8m-₪124,687,171.008.8x-5.4x0.7x
Tue, 13 Jun 2023₪776.3m₪918.8m-₪124,562,052.0011x-6.2x0.8x
Thu, 11 May 2023₪831.5m₪887.2m-₪121,765,866.008.7x-6.8x0.9x
Sat, 08 Apr 2023₪844.8m₪829.2m-₪98,399,832.0011.8x-8.6x1x
Mon, 06 Mar 2023₪880.6m₪815.6m-₪72,001,205.0013.7x-12.2x1.1x
Wed, 01 Feb 2023₪1.0b₪739.7m-₪56,343,113.0017.1x-17.9x1.4x
Fri, 30 Dec 2022₪952.4m₪739.7m-₪57,545,238.0016.6x-16.6x1.3x
Sun, 27 Nov 2022₪1.2b₪728.3m-₪56,017,375.0023.3x-22.3x1.7x
Tue, 25 Oct 2022₪1.3b₪689.4m-₪60,910,166.0031.7x-21.5x1.9x
Thu, 22 Sep 2022₪1.3b₪689.4m-₪59,162,850.0030x-22x1.9x
Sat, 20 Aug 2022₪1.6b₪781.4m-₪105,565,244.0035.3x-15x2x
Mon, 18 Jul 2022₪1.6b₪731.4m-₪119,436,825.0042.1x-13.5x2.2x
Wed, 15 Jun 2022₪1.6b₪731.4m-₪119,492,709.0041.8x-13.4x2.2x
Fri, 13 May 2022₪1.7b₪669.4m-₪124,566,867.0035.4x-13.6x2.5x
Sun, 10 Apr 2022₪1.9b₪662.6m-₪119,904,014.0037.8x-15.8x2.9x
Tue, 08 Mar 2022₪1.8b₪598.9m-₪112,324,115.0049.2x-16.3x3.1x
Thu, 03 Feb 2022₪1.8b₪598.9m-₪96,648,991.0050.5x-19.1x3.1x
Sat, 01 Jan 2022₪1.9b₪598.9m-₪95,783,207.0051.3x-19.5x3.1x
Mon, 29 Nov 2021₪2.1b₪551.1m-₪163,450,732.0049.4x-12.9x3.8x
Wed, 27 Oct 2021₪2.2b₪522.6m-₪146,671,723.0030.3x-15.2x4.3x
Fri, 24 Sep 2021₪2.4b₪515.1m-₪150,068,395.0028.3x-15.7x4.6x
Sun, 22 Aug 2021₪2.2b₪499.0m-₪147,462,423.5026.7x-15.2x4.5x
Fri, 09 Jul 2021₪2.4b₪499.0m-₪147,462,423.5029.3x-16.6x4.9x
Thu, 01 Apr 2021₪2.1b₪466.6m-₪189,880,366.5027.4x-10.9x4.4x
Sun, 03 Jan 2021₪1.8b₪442.0m-₪259,485,185.2024.8x-7x4.1x
Wed, 07 Oct 2020₪1.6b₪384.0m-₪288,523,540.9529.6x-5.6x4.2x
Price to Earnings Ratio


Total Market Cap: ₪1.6bTotal Earnings: -₪288,523,540.95Total Revenue: ₪384.0mTotal Market Cap vs Earnings and Revenue0%0%0%
Israeli Pharma Industry Price to Earnings3Y Average -12.7x202120222023
Current Industry PE
  • Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 3.0x is higher than the industry's current PS ratio of 0.72x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 36% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Comparison

How does Israeli Pharma compare with similar industries?

IL Market-0.36%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
REKA Rekah Pharmaceutical Industry₪17.696.6%
INCR InterCure₪6.424.3%
TKUN Tikun Olam-Cannbit Pharmaceuticals₪0.366.2%
SEMG Seach Medical Group₪1.741.7%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.